NCT02072161 - Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy | Biotech Hunter

Enrollment

133

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Hypercholesterolemia

Interventions

DRUG

ETC-1002

ETC-1002 capsules, taken once daily oral

DRUG

Placebo

Placebo capsules, taken once daily oral

DRUG

Statin Therapy

Patients remained on ongoing statin therapy (not study provided) of either Atorvastatin 10mg or 20mg; Simvastatin 5mg, 10mg or 20mg; Rosuvastatin 5mg or 10mg; or Pravastatin 10mg, 20mg or 40mg.

Trial Locations (40)

14609

Rochester

23294

Richmond

23502

Norfolk

28144

Salisbury

29464

Mt. Pleasant

29485

Summerville

29651

Greer

30066

Marietta

32081

Ponte Vedra

32216

Jacksonville

32765

Oviedo

33409

West Palm Beach

33511

Brandon

33606

Tampa

35662

Muscle Shoals

37660

Kingsport

39150

Port Gibson

40213

Louisville

43213

Columbus

43302

Marion

44124

Lyndhurst

45005

Franklin

45219

Cincinnati

45245

Cincinnati

46260

Indianapolis

47714

Evansville

67205

Wichita

74136

Tulsa

77030

Houston

80220

Denver

83646

Meridian

83704

Boise

84010

Bountiful

84058

Orem

85224

Chandler

90057

Los Angeles

91710

Chino

94595

Walnut Creek

95821

Sacramento

06102

Hartford